Inventor

Se-Jin Lee

Inventor

Baltimore, MD, US

Overview

1998–2020

Patent span

Chemistry

Primary field (CPC C)

Patents· 77 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides21%

A61KPreparations for medical, dental or toiletry purposes16%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%

C12NMicroorganisms or enzymes8%

A01KAnimal husbandry7%

H01LSemiconductor devices4%

H10KOrganic electric solid-state devices4%

C07DHeterocyclic compounds3%

C09KMaterials for miscellaneous applications, not provided for elsewhere3%

G01NInvestigating or analysing materials by determining their chemical or physical properties3%

PatentTitleYear

10,732,449Display device2020 10,526,342Organic heterocyclic compound and light-emitting device comprising same2020 10,529,461Heterocyclic compounds and organic light-emitting diode including the same2020 10,505,119Organic electroluminescence device2019 10,424,742Organic electroluminescent device2019 10,371,983Display device2019 10,120,233Optical member including optical fibers and multi-panel display device including the same2018 9,905,775'Organic electroluminescent device'2018 9,653,689'Condensed-cyclic compound and organic light-emitting diode including the same'2017 9,531,933'Camera module'2016 9,401,940'Terminal provided with networking module and method for receiving and transmitting data using the same'2016 9,331,286'Organic electroluminescent compounds and organic electroluminescent device using the same'2016 9,238,623'Condensed-cyclic compound and organic light-emitting diode including the same'2016 9,197,796'Camera module'2015 8,822,411'Truncated activin type II receptor and methods of use'2014 8,756,300'Terminal provided with networking module and method for receiving and transmitting data using the same'2014 8,560,656'Terminal provided with networking module and method for receiving and transmitting data using the same'2013 8,541,113'Pyrene compounds and organic electroluminescent devices using the same'2013 8,323,964'Polynucleotides encoding promyostatin polypeptides'2012 8,236,751'Methods of increasing muscle mass using follistatin-like related gene (FLRG)'2012 8,124,830'Transgenic non-human animals expressing a truncated activin type II receptor'2012 7,976,839'Growth differentiation factor-11'2011 7,732,571'Chicken growth differentiation factor-8'2010 7,572,599'Metalloprotease activation of myostatin, and methods of modulating myostatin activity'2009 7,566,768'Promyostatin peptides and methods of using same'2009 7,534,432'Methods of treating musculodegenerative disease with an antibody that binds growth differentiation factor-8'2009 7,495,075'Growth differentiation factor-16'2009 7,399,848'Polynucleotides encoding growth differentiation factor-8'2008 7,393,682'Polynucleotides encoding promyostatin polypeptides'2008 7,384,753'Growth differentiation factor-11'2008 7,381,528'Methods for detection of mutations in myostatin variants'2008 7,332,575'Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species'2008 7,270,963'Growth differentiation factor, lefty-2'2007 7,198,790'Growth differentiation factor-5'2007 7,179,884'Growth differentiation factor-8'2007 7,098,323'Growth differentiation factor-16'2006 7,074,574'Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies'2006 6,891,082'Transgenic non-human animals expressing a truncated activintype II receptor'2005 6,882,909'Method and system for reducing motor shock of a hybrid vehicle'2005 6,858,208'Growth differentiation factor-8'2005 6,713,302'Growth differentiation factor-6'2004 6,696,260'Methods to identify growth differentiation factor (GDF) binding proteins'2004 6,680,372'Antibodies specific for growth differentiation factor-7'2004 6,673,534'Methods for detection of mutations in myostatin variants'2004 6,656,475'Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same'2003 6,649,502'Methods of forming multilayer dielectric regions using varied deposition parameters'2003 6,635,480'Growth differentiation factor, lefty-2'2003 6,607,884'Methods of detecting growth differentiation factor-8'2003 6,524,802'Methods of detecting growth differentiation factor-14'2003 6,517,835'Growth differentiation factor-11'2003 6,500,664'Growth differentiation factor-8 family nucleic acid sequences'2002 6,468,535'Growth differentiation factor-8'2002 6,465,239'Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species'2002 6,428,966'Growth differentiation factor, lefty-1'2002 6,420,543'Growth differentiation factor-15'2002 6,391,565'Methods of detecting growth differentiation factor-3'2002 6,365,402'Growth differentiation factor-9'2002 6,284,632'Method for manufacturing semiconductor device with stagnated process gas'2001 6,245,896'Antibodies that binds growth differentiation factor 5'2001 6,204,047'Growth differentiation factor-10'2001 6,191,261'Growth differentiation factor-9 antibodies and methods'2001 6,130,050'Method for detection of growth differentiation factor-12 polypeptide'2000 6,096,506'Antibodies specific for growth differentiation factor-8 and methods of using same'2000 6,090,563'Growth differentiation factor-6'2000 6,030,617'Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation'2000 6,025,475'Growth differentiation factor-3'2000 6,008,434'Growth differentiation factor-11 transgenic mice'1999 5,994,618'Growth differentiation factor-8 transgenic mice'1999 5,986,058'Polynucleotide encoding growth differentiation factor-7 and protein encoded thereby'1999 5,929,213'Antibodies to growth differentiation factor-12'1999 5,914,234'Methods of detecting growth differentiation factor-11'1999 5,831,054'Polynucleotide encoding growth differentiation factor-12'1998 5,827,733'Growth differentiation factor-8 (GDF-8) and polynucleotides encoding same'1998 5,821,056'Growth differentiation factor-9'1998 5,808,007'Growth differentiation factor-3'1998 5,801,014'Growth differentiation factor-5'1998 5,770,444'Growth differentiation factor-6'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2014Patents assigned to UNIV JOHNS HOPKINS MED (53)· patent assignee history

1998–2014Based in Baltimore, MD, US· patent location history

2002–2012Patents assigned to UNIV JOHNS HOPKINS (4)· patent assignee history

2005–2020Based in Seoul, KR· patent location history

2012–2016Patents assigned to LEE SE-JIN (8)· patent assignee history

2013–2020Patents assigned to SFC CO LTD (9)· patent assignee history

2013–2020Based in Daejeon, KR· patent location history

2013–2016Based in Yongin-si, KR· patent location history

2018–2019Patents assigned to HODOGAYA CHEMICAL CO LTD (3)· patent assignee history

2018–2019Based in Chungcheongbuk-do, KR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV JOHNS HOPKINS MED	53	1998–2014
SFC CO LTD	9	2013–2020
LEE SE-JINself	8	2012–2016
UNIV JOHNS HOPKINS	4	2002–2012
HODOGAYA CHEMICAL CO LTD	3	2018–2019

Locations

Location	Patents	Span
Baltimore, Maryland, US	57	1998–2014
Seoul, KR	5	2005–2020
Daejeon, KR	4	2013–2020
Chungcheongbuk-do, KR	3	2018–2019
Yongin-si, KR	3	2013–2016